Prevention of indomethacin-induced gastric mucosal injury in Helicobacter pylori-negative healthy volunteers: A comparison study rebamipide vs famotidine

Journal of Clinical Biochemistry and Nutrition

Volumn 43, Issue 1, 2008, Pages 34-40

  Naito, Yuji ^a,b   Iinuma, Shoji ^a,b   Yagi, Nobuaki ^a   Boku, Yoshio ^a,b   Imamoto, Eiko ^b   Takagi, Tomohisa ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Hikone Central Hospital   (Japan)

Author keywords

Fomotidine; Gastric injury; Indomethacin; Rebamipide

Indexed keywords

FAMOTIDINE; INDOMETACIN; LIPID PEROXIDE; MYELOPEROXIDASE; REBAMIPIDE;

ABDOMEN FULLNESS; ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ENDOSCOPY; EPIGASTRIC PAIN; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEARTBURN; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INCIDENCE; LANZA SCORE; MALE; NAUSEA; NORMAL HUMAN; PEPTIC ULCER; PROPHYLAXIS; PROTEIN LOCALIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH MUCOSA INJURY; TISSUE DISTRIBUTION; VOMITING;

HELICOBACTER PYLORI;

EID: 50349093462     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008041     Document Type: Article

References (25)

1. Naito, Y., Kurroda, M., Mizushima, K., Takagi, T., Handa, O., Kokura, S., Yoshida, N., Ichikawa, H., and Yoshikawa, T.: Transcriptome analysis for cytoprotective actions of rebamipide against indomethacin-induced gastric mucosal injury in rats. J. Clin. Biochem. Nutr., 41, 202-210, 2007.
2. Wallace, J.L.: Pathogenesis of NSAID-induced gastro-duodenal mucosal injury. Best Pract. Res. Clin. Gastroenterol., 15, 691-703, 2001.
3. Naito, Y. and Yoshikawa, T.: Oxidative stress involvement and gene expression in indomethacin-induced gastropathy. Redox Rep., 11, 243-253, 2006.
4. Kaneko, T., Matsui, H., Shimokawa, O., Nakahara, A., and Hyodo, I.: Cellular membrane fluidity measurement by fluorescence polarization in indomethacin-induced gastric cellular injury in vitro. J. Gastroenterol., 42, 939-946, 2007.
5. Scheiman, J.M., Yeomans, N.D., Talley, N.J., Vakil, N., Chan, F.K., Tulassay, Z., Rainoldi, J.L., Szczepanski, L., Ung, K.A., Kleczkowski, D., Ahlbom, H., Naesdal, J., and Hawkey, C.: Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am. J. Gastroenterol., 101, 701-710, 2006.
6. Regula, J., Butruk, E., Dekkers, C.P., de Boer, SX, Raps, D., Simon, L., Terjung, A., Thomas, K.B., Luhmann, R., and Fischer, R.: Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. Am. J. Gastroenterol., 101, 1747-1755, 2006.
7. Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., and Kuipers, E.J.: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 56, 772-781, 2007.
8. Kamada, T., Hata, J., Kusunoki, H., Sugiu, K., Tanimoto, T., Mihara, M., Hamada, H., Kido, S., Dongmei, Q., and Haruma, K.: Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer. J. Gastroenterol. Hepatol., 21, 98-102, 2006.
9. Naito, Y, Yoshikawa, T., Iinuma, S., Yagi, N., Matsuyama, K., Boku, Y, Fujii, T., Yoshida, N., Kondo, M., and Sasaki, S.: Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig. Dis. Sci., 43, 83S-89S, 1998.
10. Lanza, F.L., Royer, G.L., Nelson, R.S., Chen, T.T., Sechman, C.E., and Rack, M.F.: A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am. J. Gastroenterol., 75, 17-21, 1981.
11. Dixson, M.F., Genta, R.M., Yardley, J.H., Correa, P., and the paticipants in the International Workshop on the Histopathology of Gastritis, H.: Classification and grading of gastritis. The updated Sydney System. Am. J. Surg. Pathol., 20, 1161-1181, 1996.
12. Ohkawa, H., Ohnishi, N., and Yagi, K.: Assay for lipid peroxides for animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351-358, 1979.
13. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J.: Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275, 1951.
14. Vergara, M., Catalan, M., Gisbert, J.P., and Calvet, X.: Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment. Pharmacol. Ther., 21, 1411-1418, 2005.
15. Yamasaki, K., Ishiyama, H., Imaizumi, T., Kanbe, T., and Yabuuchi, Y.: Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Japan J. Pharmacol., 49, 441-448, 1989.
16. Yoshikawa, T., Naito, Y., Nakamura, S., Nishimura, S., Kaneko, T., Iinuma, S., Takahashi, S., Kondo, M., and Yamasaki, K.: Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats. Arzneimittelforschung, 43, 1327-1330, 1993.
17. Murakami, K., Okajima, K., Uchiba, M., Harada, N., Johno, M., Okabe, H., and Tatsuki, K.: Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of luekocytes in rats. Dig. Dis. Sci., 42, 319-325, 1997.
18. Hiratsuka, T., Futagami, S., Shindo, T., Hamamoto, T., Ueki, N., Suzuki, K., Shinji, Y, Kusunoki, M., Shinoki, K., Wada, K., Miyake, K., Gudis, K., Tsukui, T., and Sakamoto, C.: Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression. Dig. Dis. Sci., 50 Suppl. 1, S84-89, 2005.
19. Taha, A.S., Hudson, N., Hawkey, C.J., Swannell, A.J., Trye, P.N., Cottrell, J., Mann, S.G., Simon, T.J., Sturrock, R.D., and Russell, R.I.: Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N. Engl. J. Med., 334, 1435-1439, 1996.
20. Wu, C.S., Wang, S.H., Chen, P.C., and Wu, VC.: Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?. Int. J. Clin. Pract., 52, 472-474, 1998.
21. Park, S.H., Cho, C.S., Lee, O.Y., Jun, J.B., Lin, S.R., Zhou, L.Y., Yuan, Y.Z., Li, Z.S., Hou, X.H., Zhao, H.C., Kachintorn, U., Kositchaiwat, C., and Lertkupinit, C.: Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY. J. Clin. Biochem. Nutr., 40, 148-155, 2007.
22. Yoshikawa, T., Naito, Y., Yoshida, N., and Kondo, M.: Role of reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drugs (NSAIDs)-induced gastric mucosal injury, in Frontiers of reactive oxygen species in biology and medicine, eds. By Asada, K., and Yoshikawa, K., Amsterdam, Elsevier Science B.V, pp. 235-238, 1994.
23. Yoshikawa, T. and Naito, Y.: The role of neutrophils and inflammation in gastric mucosal injury. Free Radic. Res., 33, 785-794, 2001.
24. Kim, H.K., Kim, J.I., Kim, J.K., Han, J.Y., Park, S.H., Choi, K.Y., and Chung, I.S.: Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers. Dig. Dis. Sci., 52, 1776-1782, 2007.
25. Kobayashi, K., Mizushima, Y., Yanagawa, A., Kasukawa, R., Ito, H., Koshino, T., Takami, Y., Tanaka, M., Samejima, Y., Komibuchi, T., Harada, H., Kishi, S., and Sugihara, M.: Prophylactic effects ranitidine, a H2 receptor antagonist, on gastric and duodenal lesions induced by nonsteroidal anti-inflammatory agents. The Journal of Adult Diseases, 20, 253-264, 1990.